United States · FDA National Drug Code directory
Nevirapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-505_e5515515-0ee0-e288-e053-2995a90a3d7c
- Product NDC
- 31722-505
- Form
- TABLET
- Composition / generic term
- Nevirapine
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120523
- Source listing expiry
- 20261231
Source-listed ingredients
- NEVIRAPINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (31722-505-01) · 31722-505-01
- 500 TABLET in 1 BOTTLE (31722-505-05) · 31722-505-05
- 1000 TABLET in 1 BOTTLE (31722-505-10) · 31722-505-10
- 60 TABLET in 1 BOTTLE (31722-505-60) · 31722-505-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →